𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efficacy and Safety of DALI-LDL-Apheresis in Two Patients Treated with the Angiotensin II-Receptor 1 Antagonist Losartan

✍ Scribed by Thomas Bosch; Thorsten Wendler

Book ID: 109097168
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 71 KB
Volume: 8
Category: Article
ISSN: 1091-6660
DOI: 10.1111/j.1526-0968.2004.00162.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ABPM comparison of the antihypertensive

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

✍ Mallion, J M; Siche, J P; Lacourcière, Y 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Interim evidence of the renoprotective e

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

✍ Yasuhiko Iino; Matsuhiko Hayashi; Tetsuya Kawamura; Tatsuo Shiigai; Yasuhiko Tom 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 613 KB

Effects of the angiotensin II type 1 rec

Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy

✍ Atsuhisa Sato; Mitsuhisa Tabata; Koichi Hayashi; Takao Saruta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 273 KB